AVE 33.3% 0.2¢ avecho biotechnology limited

Ann: Phosphagenics ProPhase Arbitration Ruling Handed Down, page-81

  1. 4,157 Posts.
    lightbulb Created with Sketch. 67
    https://www.ncbi.nlm.gov/pmc/articles/PMC2598771/

    Jev/Reilly/ you believe TPM is a 'novel' lipid based transdermal drug delivery
    If you type in 'tpgs lipid' into Google you will find lots of peer reviewed papers and books about TPGS on the subject ur claiming TPM has ownership. TPGS does everything that TPM hopes to and is already in the market GRAS approved with drugs been delivered and is in other multiple P1,2,3 trials !
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.2¢ 0.3¢ 0.2¢ $2.634K 1.064M

Buyers (Bids)

No. Vol. Price($)
56 92244418 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 60312650 22
View Market Depth
Last trade - 13.20pm 26/08/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.